Global HIV/AIDS Spending 2000-2017

Research by the Global Burden of Disease Health Financing Collaborator Network estimated HIV/AIDS spending for 134 low- and middle-income countries for 2000-2017. The estimates cover HIV/AIDS spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private) and development assistance for health (DAH). Spending is also disaggregated by function, including care and treatment, prevention, and other spending. Domestic HIV/AIDS spending by source and function was estimated based on data from sources including National AIDS Spending Assessments (NASA), the Global Fund, WHO National Health Accounts and sub-accounts, UNAIDS Global AIDS Response Progress Reports (GARPR), the GARPR database, UNAIDS health financing dashboard, and the AIDS data hub. Development assistance for HIV/AIDS data were drawn from IHME's 2019 Development Assistance for Health Database. Estimates are reported in constant 2019 United States dollars.

全球疾病负担卫生筹资协作网络（Global Burden of Disease Health Financing Collaborator Network）的研究团队，对2000年至2017年间134个中低收入国家的艾滋病相关支出完成了估算。本次估算覆盖两类细分维度：其一按筹资来源划分为三类国内筹资类别——政府出资、自费支出与预付式私人筹资，以及卫生领域发展援助（development assistance for health, DAH）；其二按功能划分为护理与治疗、预防及其他相关支出三类。按筹资来源与功能细分的国内艾滋病相关支出估算，基于多源数据，包括全国艾滋病筹资评估（National AIDS Spending Assessments, NASA）、全球基金、世界卫生组织国家卫生账户及子账户、联合国艾滋病规划署全球艾滋病应对进展报告（Global AIDS Response Progress Reports, GARPR）及其数据库、联合国艾滋病规划署卫生筹资仪表盘，以及艾滋病数据枢纽。艾滋病相关发展援助数据则取自IHME 2019年卫生发展援助数据库。所有估算值均以2019年不变价美元进行报告。